AstraZeneca (AZN) Tops Q1 EPS by 23c
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Trade AZN Now!
AstraZeneca (NYSE: AZN) reported Q1 EPS of $2.23, $0.23 better than the analyst estimate of $2.00. Revenue for the quarter came in at $8.29 billion versus the consensus estimate of $8.43 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
- Zumiez, Inc. (ZUMZ) Tops Q1 EPS by 1c; Guides In-Line
Create E-mail Alert Related Categories
Earnings, Hot Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
